Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the Reference Yield and Total Consideration (as set forth in the table below) to be paid in connection with its previously announced cash tender offer (the "Offer") by its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the "Company"), to purchase the outstanding notes described below, upon the terms and subject to the conditions set forth in the Offer to Purchase dated September 17, 2026 (the "Offer to Purchase"). The Company is offering to purchase in the Offer its 3.875% Senior Secured Notes due 2028 (the "Notes") for the consideration described below, subject to a $75,000,000 cap on the aggregate principal amount of Notes purchased in the Offer (the "Tender Cap") subject to proration and the terms and conditions set forth in the Offer to Purchase. Subject to applicable law, the Company may, but is under no obligation to, eliminate, increase or decrease the Tender Cap at any time prior to the "Expiration Date" of 5:00 p.m., New York City time, on September 23, 2026 (unless extended or earlier terminated by the Company). In the event proration is required with respect to the Notes, the Company will multiply the principal amount of each valid tender of such Notes by the proration rate and round the resulting amount down to the nearest $1,000 principal amount in order to determine the principal amount of such tender that will be accepted pursuant to the Offer. The excess principal amount of Notes not accepted from the tendering Holders will be promptly returned to such Holders, and if this excess principal amount of Notes is less than $2,000, the Company may either accept or reject all such tendering Holders' validly tendered Notes in its sole discretion. Additionally, the Company may increase the amount of Notes accepted for payment in the Offer by no more than 2% of the outstanding Notes without amending or extending the Offer. The Offer to Purchase and any related documents are referred to herein collectively as the "Tender Offer Documents". Capitalized terms used but not defined in this press release have the meanings given to them in the Offer to Purchase. Certain information regarding the Notes and the pricing for the Offer is set forth in the table below. Notes Issuer CUSIP / ISIN Number (1) Aggregate Principal Amount Outstanding Reference Security Reference Yield (2) Bloomberg Reference Page Fixed Spread (Basis Points) Total Consideration (3) 3.875% Senior Secured Notes due 2028 Clarivate Science Holdings Corporation 144A: 18064P AC3 / US18064PAC32 Reg S: U1800Q AC3 / USU1800QAC34 $825,000,000 4.125% UST due June 30, 2028 4.864 % FIT 4 +50 $975.15 _____________ (1) No representation is made as to the correctness or accuracy of the CUSIP or ISIN numbers listed above. (2) The Reference Yield was determined at 2:00 p.m., New York time, on September 23, 2026. (3) Represents the total consideration for the Notes (the "Total Consideration") payable per each $1,000 principal amount of the Notes validly tendered and accepted for purchase in the Offer. The "Total Consideration" payable per each $1,000 principal amount of Notes validly tendered for purchase is based on the Fixed Spread, plus the Reference Yield based on the bid-side price of the Reference Security as quoted on the Bloomberg Reference Page as of 2:00 p.m., New York City time, today, September 23, 2026 (the "Price Determination Date"). In addition to the Total Consideration, Holders whose Notes are accepted for purchase pursuant to the Offer will receive accrued and unpaid interest on those Notes from the last interest payment date with respect to those Notes to, but excluding, the Settlement Date (the "Accrued Interest," and the payment thereof, the "Accrued Coupon Payment"). Tenders of Notes may be validly withdrawn at any time at or prior to 5:00 p.m., New York City time, today, Septemb...